ArticleNeuro-oncology2023

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma.

Lena Hänsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.